Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Tracking well but all eyes will be on the Berry deal

Amcor
3:27pm
February 5, 2025
AMC’s 1H25 result on a constant currency basis was in line with expectations with management reiterating guidance for the full year. Key positives: Volumes continued to improve sequentially; EBIT margin was higher in both Flexibles (+30bp to 12.9%) and Rigid Packaging (+70bp to 7.3%) supported by cost-out and restructuring benefits; ROFE increased 50bp to 15.0%. Key negative: Ongoing destocking in the healthcare sector once again had a negative impact on price/mix, although management said this has now largely run its course with volumes expected to improve in 2H25. AMC said the merger with Berry Global is on track with the respective shareholder meetings to take place on 25 February. We make minimal changes to earnings forecasts. However, a roll-forward of our model to FY26 forecasts and updates to FX (particularly a lower AUD/USD) see our target price rise to $16.45 (from $15.75). Hold rating maintained.

International flywheel coming to life

Pinnacle Investment Mgmt
3:27pm
February 5, 2025
PNI delivered 1H25 NPAT of A$75.7m, up 150% on pcp. Affiliate earnings grew 100% to A$74.3m; and 52% to A$37.9m excluding performance fees (PF). Half-on-half, Affiliate earnings (ex-performance fees) grew 9.6%; and group core earnings (ex PF and principal investments) grew +8.4% (pre-tax) to A$30.4m. Group FUM closed at A$155.4bn, +41% for the half (+16% ex-acquisitions). FUM growth comprised acquisitions A$27.9bn; inflows A$6.7bn; performance A$10.7bn. 2H25 expectations are supported by ~6% higher starting FUM (pre acquisitions); acquisition contributions; and typical 2H earnings skews in certain managers. Medium-term ‘embedded’ drivers are visible from the scaling of several managers; and the long-term offshore opportunity is significant. PNI is arguably expensive on near-term valuation multiples (susceptible to short-term volatility), however we see embedded strong growth medium term; the operating structure is now expanded to facilitate ongoing offshore growth; and near-term catalysts look supportive (accelerating flows CY25; acquisitions).

International Spotlight

H&M
3:27pm
February 4, 2025
H&M Hennes & Mauritz AB is a multinational fashion and design group conglomerate based in Vasteras, Sweden. Its 11 brands include H&M, COS, Weekday, Monki, H&M Home, & Other Stories, Arket, Afound, The Singular Society, Creator Studio and Sellpy. Across these brands, its main operating segment is affordable and sustainable wardrobe essentials, but it also offers fashion pieces and unique designer collaborations, accessories, stationery, homewares, shoes, bags and beauty products. H&M Group operates over 4,300 stores worldwide. 

Rigs to riches

Vysarn
3:27pm
February 4, 2025
We initiate on Vysarn (VYS) with a Speculative Buy rating and a 55cps target price. VYS is a well-led, diversified, high margin (>10% NPAT), integrated water services provider with significant growth prospects and a strong balance sheet (net cash). We forecast EPS growth of +14% and +25% in FY25 and FY26, respectively. For FY26, we believe earnings risk is skewed to the upside if the company can replicate past performance by accelerating growth for recently acquired businesses. In our view, the core business (all divisions except Vysarn Asset Management) underpins a valuation of 46cps, which means at the current share price the more speculative asset management business comes as a free option.

4Q24 Quarterly Update

Frontier Digital Ventures
3:27pm
February 4, 2025
FDV’s 4Q24 update was relatively soft overall, in our view, with both revenue and EBITDA growth being impacted by tough operating conditions, and a restructure of the InfoCasas transaction model. FDV’s fundamental problem at the moment in our view, is it is not growing with group Revenue and EBITDA largely stagnant during FY22-FY24.  The LATAM strategic review may unlock value, but headwinds in this business unit may also limit upside from this review. We lower FDV FY24F/FY25F EPS by ~5% to >10% (off low bases) on softer revenue growth and EBITDA margin assumptions near term. Our PT is reduced to A$0. (previously A$0.61). We think there is clearly long-term value in FDV given its assembled portfolio, and hence we maintain our ADD call, but we acknowledge the market needs to see evidence of momentum before FDV re-rates.

Patience to yield rewards

Mitchell Services
3:27pm
February 4, 2025
2Q financials fell below our expectations, primarily as MSV’s build-up into new contracts and capabilities has stepped up more quickly than expected. We trim our FY25 forecasts/valuation to reflect the delay to higher rig utilisation. FY25 performance and dividends have been crimped by MSV’s current ‘transition period’. However, FY26 looks strongly set up for higher earnings, cash conversion/ release and higher dividends/ returns. MSV remains too cheap on all value measures and suits patient investors.

Major clinical trials to read out soon – key inflection point

Opthea
3:27pm
February 3, 2025
Opthea (OPT) is a biopharmaceutical company developing a potential treatment for wet age-related macular degeneration (wet AMD), a serious eye condition effecting 3.1m people in the US and Europe. The existing market for current treatments is estimated by management at US$15bn. Two major clinical trials are due to read out within the next 6 months and if successful, approval in the US is anticipated in 2HCY26. Consensus has a target price of A$2.07 compared with the current price of $1.07. We have prepared a brief note outlining the upcoming clinical trials and timelines noting the near-term catalysts are binary and appropriate for investors with a higher risk profile.

International Spotlight

General Motors Company
3:27pm
February 3, 2025
General Motors Company (GM-US), headquartered in Detroit, is a global automotive company known for brands like Chevrolet and Cadillac, offering a diverse portfolio of vehicles. A market leader with considerable scale, GM has global operations and employs over 165,000 staff worldwide.

2Q beat- sales mixed, but growth drivers remain intact

ResMed Inc
3:27pm
February 3, 2025
2Q results were above expectations, with double-digit top and bottom line growth, expanding margins and strong cash flow. The Americans posted strong, above market growth, with product segments benefiting from new patient set-ups/new releases and market leading cloud-connected device platforms, while ROW tracked the market and residential care software sales slowed, but inked double-digit profit gains. Despite a 30bp FX headwind, GPM surprised to the upside (yet again), with FY25 still targeting 59-60%, but 2HFY25 expected to be above 1HFY25 (59.2%). While sales diverged, we continue to view RMD as well positioned to benefit from growing sleep disorder awareness around trends in consumables and weight loss drugs. FY25-27 earnings increase up to 1.1%, with our target price rising to $43.60. Add.

A big opportunity and executing well

Findi
3:27pm
January 31, 2025
Findi (FND) is an ASX-listed fintech that operates in India’s large and fast-growing market. It has ~215k ATM/payment locations and processes >1 billion transactions per year. FND operates two key businesses: 1) an ATM solutions business, which deploys and manages ATMs through both Brown Label (BLA) and White Label ATM (WLA) agreements; and 2) a ‘Digital’ payments business (Findipay + BankIT), focused on dynamic payments and digital banking. The attraction of the FND story, in our view, is its established BLA operations, which give it a solid foothold in the sizeable Indian ATM/payments market. Furthermore, the areas management is targeting for future expansion (WLA and Digital) are far less capital intensive than FND’s traditional BLA operations, which should facilitate increasing returns and cashflow. We initiate coverage on FND with an ADD rating, with the stock trading at a ~40% discount to our A$7.17 blended valuation.

News & Insights

Michael Knox outlines the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and his own analysis for Australia.

Today, I’m presenting the first page of my updated presentation, which focuses on GDP growth and inflation expectations for major economies. Before diving into that, I want to clarify a point about U.S. trade negotiations that has confused some media outlets.

In the previous Trump Administration ,there was single trade negotiator, Robert Lighthizer, held a cabinet position with the rank of Ambassador. This time, to expedite negotiations and give them more weight, Trump has appointed two additional cabinet-level officials to handle trade talks with different regions. For Asian economies, Scott Bessent and Ambassador Jamison Greer, who succeeded Lighthizer and previously served on the White House staff, are managing negotiations, including those with China. For Europe, Howard Lutnick, the Commerce Secretary, and Ambassador Greer are negotiating with the European Trade Representative. When the EU representative visits Washington, D.C., they meet with Lutnick and Greer, while Chinese or Japanese representatives engage with Bessent and Greer.

In my presentation today, I’m outlining the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and my own analysis for Australia.

For the U.S., the best-case scenario is a soft landing, with growth slowing but remaining positive at 1.3% this year and rising to 1.7% next year. This slowdown allows the Federal Reserve to continue cutting interest rates, leading to a decline in the U.S. dollar. This in turn ,triggers a recovery in commodity prices. These prices have stabilized and are now trending upward, with an expected acceleration as the dollar weakens.

U.S. headline inflation is projected to be just below 3% next year, with higher figures this year driven by tariff effects.



Global Economic Perspective

In the Euro area, growth is accelerating slightly, from just under 1% this year to 1.2% next year, with inflation expected to hit the 2% target this year and dip to 1.9% next year.

China’s GDP growth is forecast  at 4% for both this year and next, a step down from previous 5% rates, reflecting a significant slump in domestic demand and very low inflation  Chinese Inflation is only  :   0.2% last year, 0.4% this year, and 0.9% next year.  Despite a massive fiscal push, with a budget deficit around 8% of GDP, China’s debt-to-GDP ratio is rising faster than the U.S.. Yet this is  yielding more modest  domestic growth.

India, on the other hand, continues to outperform, with 6.5% GDP growth last year, 6.2% this year, and  6.3%  next year, surpassing earlier projections.

Read more
In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia.

Positive earnings surprise

In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia. For all the volatility in markets caused by US trade policy, the results were positive. For all the 187 high profile and blue-chip companies in our International Watchlist, the median EPS beat vs consensus was 3.2%, nearly twice that recorded in the December quarter (1.8%). 37% of companies exceeded consensus EPS expectations by more than 5% and only 9% missed by more than 5%. Communication Services was the most positive sector, led by Magnificent 7 companies Alphabet and Meta Platforms. The median EPS beat in that sector was 13%. Consumer Discretionary was the biggest disappointment (though only a mild one) with EPS falling 0.6% short of analyst estimates on a median basis.

Alphabet and Meta among the best performers

Across our Watchlist, some of the best performing stocks in terms of EPS beats were Alphabet, Boeing, Uniqlo-owner Fast Retailing, Meta Platforms, Newmont and The Walt Disney Company. Notable misses came from insurance broker Aon, BP, PepsiCo, Starbucks, Tesla and UnitedHealth. The latter saw by far the worst share price performance over reporting season, its earnings weakness compounded by the resignation of its CEO and the launch of a fraud investigation by the Department of Justice. British luxury fashion label Burberry had the best performing share price as it gains traction in its turnaround plan.

Tariffs were the main talking point (of course)

The timing of President Trump’s ‘Liberation Day’ on 2 April, just before the March quarter results started rolling in, guaranteed that US tariffs would be the main talking point throughout reporting season. Most companies took the line that higher tariffs presented a material risk to global growth and inflation. The rapidly shifting sands of US trade policy mean the impact of tariffs is highly uncertain. This didn’t stop many companies from trying to estimate the impact on their profits. This ranged from the very precise ($850m said RTX) to the extremely vague (‘a few hundred million dollars’ hazarded Abbott Laboratories). The rehabilitation of AI as a systemic driver of long-term value was a key theme of reporting season, with many companies reporting what Palantir Technologies described as an ‘unstoppable whirlwind of demand’ and others indicating an increase in planned AI investment. The deterioration in consumer confidence was another key talking point, though most companies could only express concern about a possible future softening in demand rather than any actual evidence of a hit to sales.

Our International Focus List continues to outperform

In this report, we also report on the performance of the Morgans International Focus List, which is now up 25.3% since inception last year, outperforming the benchmark S&P 500 by 20.4%.


Morgans clients receive exclusive insights such as access to our latest International Reporting Season article.

Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more
The U.S. and China, through negotiations led by the Chinese Deputy Premier and U.S. Treasury Secretary Scott Bessent, agreed to a 90-day tariff reduction from over 125% to 30% and 10% respectively

US and Chinese actions had led to an unintended embargo of trade between the world’s two largest economies.

In recent days there has been discussion of the temporary “cease fire” in the tariff war between the US and China.

The situation was that both countries had levied tariffs on each other more than 125%. This had led to a mutual embargo of trade between the two world is two largest economies. Then as a result of negotiation between the Deputy Premier of China and US Treasury Secretary Scott Bessent both China and the US agreed to a 90 day pause in “hostilities” where both sides agreed to reduce the US tariff on the China to 30 percent and the Chinese tariff on the US to 10%.

Some suggested that this meant that “China had won” others suggested that the “US had won.” To us this really suggests that both parties were playing in a different game. The was a game in which both sides had won.

To understand why this is the case we must understand a little of the theory of this type of competition. Economists usually use discuss competition in terms of markets where millions of people are involved. In such a case we find a solution by finding the intersection of supply and demand which model the exchange between vast numbers of people.

But here we are ware talking of a competition where only two parties are involved.

When exceedingly small numbers like this are involved, we find the solution to the competition by what is called “Game Theory.”

In this game there are only two players. One is called China, and the other is called the US. Game theory teaches us that are there three different types of games. The first is a zero-sum game. In this game there two sides are competing over a fixed amount of product. Again, this is called " A zero sum game “. Either one party gets a bigger share of the total sum at stake and the other side gets less. This zero-sum game is how most of the Media views the competition between the US and China.

A second form is a decreasing sum game. An example of this is a war. Some of the total amount that is fought over is destroyed in the process. Usually both sides will wind up worse than when they started.

Then there is a third form. This form is called an ‘increasing sum game.’ This is where both sides cooperate so that the total sum in the game grows because of this cooperation. We think that what happened in the US and China negotiation was an increasing sum game.

As Scott Bessent said at the Saudi Investment Forum in Riyadh soon after the agreement was signed, “both sides came with a clear agenda with shared interests and great mutual respect.”

He said, “after the weekend, we now have a mechanism to avoid escalation like we had before. We both agreed to bring the tariff levels down by 115% which I think is very productive because where we were with 145% and 125% was an unintended embargo. That is not healthy for the two largest economies in the world.”

He went on, “when President Trump began the tariff program, we had a plan, we had a process. What we did not have with the Chinese was a mechanism. The Vice Premier and I now call this the ‘Geneva mechanism’”.

Both sides cooperated to make both sides better off. Bessent added “what we do not want, and both sides agreed, is a generalised decoupling between the two largest economies in the world. What we want is the US to decouple in strategic industries, medicine, semiconductors, other strategic areas. As to other countries; we have had very productive discussions with Japan, South Korea, Indonesia, Taiwan, Thailand. Europe may have collective action problems with the French wanting one thing and the Italians wanting a different thing. but I am confident that with Europe, we will arrive at a satisfactory conclusion.

We have a very good framework. I think we can proceed from here.”

What we think we can see here is that the United States and China have cooperated to both become better off. This is what we call an increasing sum game.

They will continue their negotiation using that approach. This will do much to allay the concerns that so many had about the effect of these new tariffs.

Read more